2014
Press Releases
-
Benaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
-
Benaroya Research Institute Receives $2.2 Million to Discover Biomarker That Triggers Allergies
-
Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good
-
Benaroya Research Institute Scientists Identify Drivers of Rheumatoid Arthritis
-
Research and Healthcare Organizations Form the Seattle Food Allergy Consortium (SeaFAC) to Bring New Treatments and Research to the Northwest
-
Benaroya Research Institute Evaluates Immunology Approach to Blocking Breast Cancer
-
Modular Repertoire Analysis Offers Breakthrough Approach for Systems Immunology
-
Thomas L. Skillman Joins BRI as the First Director of Research Technology
-
Benaroya Research Institute Receives 7-Year Award to Lead Immune Tolerance Network
2013
Press Releases
-
First Study to Investigate the Human Genome in Multiple Sclerosis
-
Researchers Use Web 2.0 Apps to Share Vaccine Study
-
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
-
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
-
Benaroya Research Institute Welcomes New Board Members
-
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
Benaroya Research Institute to Unravel Insulin Mystery in Type 1 Diabetes: $1.4 Million Grant from JDRF to Understand Critical Question
Benaroya Research Institute Receives $2.2 Million to Discover Biomarker That Triggers Allergies
Immune Tolerance Network’s TrialShare Recognized for Using Data for Public Good
Benaroya Research Institute Scientists Identify Drivers of Rheumatoid Arthritis
Research and Healthcare Organizations Form the Seattle Food Allergy Consortium (SeaFAC) to Bring New Treatments and Research to the Northwest
Benaroya Research Institute Evaluates Immunology Approach to Blocking Breast Cancer
Modular Repertoire Analysis Offers Breakthrough Approach for Systems Immunology
Thomas L. Skillman Joins BRI as the First Director of Research Technology
Benaroya Research Institute Receives 7-Year Award to Lead Immune Tolerance Network
-
First Study to Investigate the Human Genome in Multiple Sclerosis
-
Researchers Use Web 2.0 Apps to Share Vaccine Study
-
Genome Sequencing of the Living Coelacanth Sheds Light on the Evolution of Land Vertebrates
-
Benaroya Research Institute Announces $4.4 Million Grant for Type 1 Diabetes
-
Benaroya Research Institute Welcomes New Board Members
-
BRI Researchers Identify Biomarker and Potential Therapy Target in Multiple Sclerosis
